3-hydroxy-10-keto-N-cyclobutylmethylmorphinan | 529495-65-6

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 吗啡烷
• 英文名称: 3-hydroxy-10-keto-N-cyclobutylmethylmorphinan
• 英文别名: MCL 158；(1R,9S,10R)-17-(cyclobutylmethyl)-4-hydroxy-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-8-one
• CAS: 529495-65-6
• 化学式: C₂₁H₂₇NO₂
• 分子量: 325.451
• InChiKey: OOATVKPPMTVMQN-HFSMHLIXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  24
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  40.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-hydroxy-10-keto-N-cyclobutylmethylmorphinan 在 4,7,13,16,21,24-六氧-1,10-二氮双环[8.8.8]二十六烷 palladium diacetate 、 N,N,N′,N′-tetraphenyl-1,1′-binaphthalene-2,2′-diamine 、 盐酸羟胺 、 sodium acetate 、 caesium carbonate 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 为溶剂， 反应 48.0h， 生成 MCL 167
  参考文献：
  名称：

  2-Aminothiazole-Derived Opioids. Bioisosteric Replacement of Phenols

  摘要：

  A series of aminothiazole-derived morphinans, benzomorphans, and morphine were synthesized. Although their affinities were somewhat lower than their phenol prototypes, one compound (9a, ATPM) has been identified possessing high affinity and selectivity at the kappa receptor. Functional assays showed that 9a was a full kappa but partial mu agonist; the efficacy at kappa was significantly greater than at mu receptors. This novel compound may be valuable for the development of long-acting analgesics and drug abuse medication.

  DOI：

  10.1021/jm049978n
• 作为产物：
  描述：

  溴甲基环丁烷 、 3-Hydroxy-normorphinan 在 碳酸氢钠 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 24.0h， 以47%的产率得到3-hydroxy-10-keto-N-cyclobutylmethylmorphinan
  参考文献：
  名称：

  10-酮吗啡喃和3-取代的3-脱氧吗啡喃类似物作为混合的κ和微阿片样物质配体：它们在阿片样物质受体上的结合亲和力的合成和生物学评估。

  摘要：

  合成了一系列10-酮吗啡喃类似物，并研究了它们在所有三个阿片受体上的结合亲和力。在大多数情况下，观察到对micro和kappa受体的亲和力高，而对delta受体的亲和力较低，因此对micro和kappa受体的选择性好。在氮位置上可以容纳各种各样的取代基。N-（S）-四氢糠基类似物11在所有三个受体上显示出最高的亲和力。N-环丁基甲基类似物13对κ受体具有高亲和力和选择性，而N-2-苯基乙基类似物18对微受体具有良好的亲和力和选择性。对3-取代基的进一步修饰表明，一个H键供体是在微受体和κ受体上具有良好亲和力的基本要求。在吗啡烷的3-OH基团上研究了类似的修饰：左啡烷（2a），环烷（2b）和缺少10-酮基的MCL-101（2c）。3-氨基生物立体异构体（40和41）在微受体和kappa受体上表现出相当好的亲和力。吗啡亚系列中的3-甲酰胺基取代（化合物46-48）产生的亲和力与其相应的3-OH

  DOI：

  10.1021/jm0304156

文献信息

• Mixed kappa/mu opioids and uses thereof
  申请人：——

  公开号：US20040259901A1

  公开（公告）日：2004-12-23

  This invention features opioid compounds having activity at kappa and mu receptors, methods for preparing the mu/kappa opioids, and methods for the treatment of pain or a dopamine dysregulation disease, such as schizophrenia, attention deficit hyperactivity disorder (ADHD), attention deficit hyperactivity disorder (ADD), Parkinson's disease, hyperprolactinemia, depression, and addiction.

  本发明的特点是在卡巴受体和μ受体上具有活性的阿片类化合物、制备μ/卡巴阿片类化合物的方法以及治疗疼痛或多巴胺调节失调疾病（如精神分裂症、注意力缺陷多动障碍（ADHD）、注意力缺陷多动障碍（ADD）、帕金森病、高泌乳素血症、抑郁症和成瘾）的方法。
• Microwave-Promoted Pd-Catalyzed Cyanation of Aryl Triflates:  A Fast and Versatile Access to 3-Cyano-3-desoxy-10-ketomorphinans
  作者：Ao Zhang、John L. Neumeyer

  DOI：10.1021/ol027256p

  日期：2003.1.1

  [GRAPHICS]A methodology for the microwave-promoted conversion of triflates to the corresponding nitriles by using 8% equiv of Pd(Ph3P)(4) as the catalyst and 2.0 equiv of Zn(CN)(2) as the cyanide source has been developed. This method is highly efficient for the preparation of 3-cyano-3-desoxy10-ketomorphinans. The reaction was generally completed in 15 min at 200 degreesC and produced products in greater than 86% yields.
• US7271173B2
  申请人：——

  公开号：US7271173B2

  公开（公告）日：2007-09-18
• [EN] MIXED KAPPA/MU OPIOIDS AND USES THEREOF<br/>[FR] OPIOIDES MIXTES KAPPA/MU ET UTILISATIONS DE CES DERNIERS
  申请人：MCLEAN HOSPITAL CORP

  公开号：WO2004045562A2

  公开（公告）日：2004-06-03

  This invention features opioid compounds having activity at kappa and mu receptors, methods for preparing the mu/kappa opioids, and methods for the treatment of pain or a dopamine dysregulation disease, such as schizophrenia, attention deficit hyperactivity disorder (ADHD), attention deficit hyperactivity disorder (ADD), Parkinson’s disease, hyperprolactinemia, depression, and addiction.
• 2-Aminothiazole-Derived Opioids. Bioisosteric Replacement of Phenols
  作者：Ao Zhang、Wennan Xiong、James E. Hilbert、Emily K. DeVita、Jean M. Bidlack、John L. Neumeyer

  DOI：10.1021/jm049978n

  日期：2004.4.1

  A series of aminothiazole-derived morphinans, benzomorphans, and morphine were synthesized. Although their affinities were somewhat lower than their phenol prototypes, one compound (9a, ATPM) has been identified possessing high affinity and selectivity at the kappa receptor. Functional assays showed that 9a was a full kappa but partial mu agonist; the efficacy at kappa was significantly greater than at mu receptors. This novel compound may be valuable for the development of long-acting analgesics and drug abuse medication.